Гаїсян Фарма: Партнерська компанія Huayi Taikang подала заявку на публічне розміщення акцій для необмеженого кола кваліфікованих інвесторів та їхнє котирування на Пекінській біржі, яка була прийнята до розгляду.

Haitian Pharmaceutical announces that the application of Huayi Taikang Pharmaceutical Co., Ltd., in which the company holds shares, for a public offering of stocks to qualified investors and listing on the Beijing Stock Exchange has been accepted by the Beijing Stock Exchange. Huayi Taikang received the “Acceptance Notice” issued by the Beijing Stock Exchange on March 31, 2026. As of the disclosure date of this announcement, Haitian Pharmaceutical holds 1.112 million shares of Huayi Taikang, accounting for 1.85% of its total shares. Huayi Taikang’s listing application still requires approval from the Beijing Stock Exchange and registration approval from the China Securities Regulatory Commission, and the final outcome is uncertain.